IonQ Completes Acquisition of Oxford Ionics in $1.075 Billion Deal

dMY Technology Group III Completes Business Combination with IonQ

September 30, 2021

AI & Machine Learning

dMY Technology Group, Inc. III completed its previously announced business combination with IonQ, Inc., and the combined company began trading on the NYSE under the ticker IONQ on October 1, 2021. The transaction provided IonQ with approximately $636 million in gross proceeds to fund growth and accelerate commercialization of its trapped‑ion quantum computing systems and cloud services.

IonQ Acquires Controlling Stake in ID Quantique

May 6, 2025

Cybersecurity

IonQ has completed the acquisition of a controlling stake in ID Quantique (IDQ), adding IDQ's quantum key distribution (QKD) systems, quantum random number generators (QRNGs) and single-photon detectors to its product portfolio. The deal expands IonQ's quantum networking and secure-communications capabilities, brings nearly 300 granted and pending patents to IonQ's IP estate, and strengthens its position in national and international quantum communications initiatives.

IonQ Acquires Lightsynq

June 3, 2025

Telecommunications

IonQ has completed the acquisition of Boston-based Lightsynq, a startup developing photonic interconnects and quantum memory. The deal adds Lightsynq's IP and engineering capabilities to accelerate IonQ's fault-tolerant quantum computing roadmap and progress toward quantum networking and the quantum internet.

IonQ Acquires Capella Space

July 15, 2025

Aerospace & Defense

IonQ has completed its acquisition of Capella Space, integrating Capella's synthetic aperture radar (SAR) satellite capabilities with IonQ's quantum technologies. The deal positions IonQ to develop a space-based quantum key distribution (QKD) network and a quantum-enabled Earth observation platform for government and commercial customers.

AI/ML Innovations Inc. Acquires Quantum Sciences Ltd

December 10, 2024

AI & Machine Learning

AI/ML Innovations Inc. entered into a binding share purchase agreement to acquire all issued and outstanding shares of Quantum Sciences Ltd for a purchase price of $690,000 to be paid by the issuance of 10,000,000 common shares. The acquisition (SPA dated December 9, 2024) brings digital health AI/ML and quantum‑inspired capability into AI/ML Innovations' portfolio and remains subject to customary closing conditions and CSE approval.

Quanterix Completes Acquisition of Akoya Biosciences

July 8, 2025

Healthcare Services

Quanterix completed its previously announced acquisition of Akoya Biosciences under an amended merger agreement. The deal calls for Quanterix to issue about 7.8 million shares and pay about $20 million in cash to Akoya shareholders and other Akoya equity award holders.